Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat
Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat
Related Posts
Protests against Elon Musk target Tesla dealerships; Sheryl Crow ditches the brand
The Grammy-winning artist posted “So long Tesla” to Instagram as a majority of Americans don’t want Musk serving in Trump’s…
FTC’s Khan urges agency to ‘stay aggressive’ after she goes
A progressive icon, Khan became the youngest person ever to chair the FTC at age 32 after an article she wrote…
Netflix doubled revenue from ads last year and still raised prices on all subscription tiers
The streaming giant doubled ad revenue last year, and expects to double it again this year. Read More